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Primary amoebic meningoencephalitis: amoebicidal effects of
clinically approved drugs against Naegleria fowleri
Naegleria fowleri is a protist pathogen
known to produce fulminating primary
amoebic meningoencephalitis (PAM)
(Marciano-Cabral & Cabral, 2007;
Visvesvara et al., 2007). Although rare,
PAM is a serious human disease with a
fatality rate of .95%. It is generally
associated with swimming in contaminated
freshwater and possibly through nasal
irrigation for cleansing (Marciano-Cabral &
Cabral, 2007; Visvesvara et al., 2007). PAM
cases have recently been observed in
Muslims who routinely perform ritual
ablution, which involves repeated water
exposure to the nostrils for cleansing
(Siddiqui & Khan, 2011). These so-called
‘brain-eating amoebae’ invade the nervous
system via the nose when contaminated
water is deeply inhaled into the nose, and
migrate to the brain tissue where severe
haemorrhaging and inflammation are
caused, resulting in widespread brain tissue
destruction (Marciano-Cabral & Cabral,
2007; Visvesvara et al., 2007). As well
studied as this protist is, we still do not
know of any effective chemotherapeutic
interventions. The current treatment
regimen involves a mixture of drugs
ranging from antimicrobial compounds to
experimental anti-cancer drugs (Marciano-
Cabral & Cabral, 2007; Visvesvara et al.,
2007), to provide additive or synergistic
effects, but even then the mortality remains
very high (~98%) (Marciano-Cabral &
Cabral, 2007; Visvesvara et al., 2007). This is
probably due to difficulties in early
diagnosis, resulting in delayed initiation of
effective chemotherapy, and/or poor
penetration of antimicrobial compounds
across the blood–brain barrier. With the
devastating nature of this disease and the
problems associated with its chemotherapy,
the overall aim of the present study was to
test anti-N. fowleri effects of clinically
available drugs in vitro.
All chemicals were purchased from Sigma,
unless otherwise stated. Among the various
drugs tested, amlodipine, apomorphine
and loperamide were purchased from
Sigma, procyclidine was purchased from
Auden McKenzie Pharma, haloperidol was
purchased from Searle Pharma,
amiodarone was purchased from Sanofi-
Aventis and digoxin was purchased from
GlaxoSmithKline. The drugs tested in the
present study and their known mode(s) of
action are listed in Table 1. All drugs tested
are available clinically and approved by the
Food and Drug Administration and/or
European Union drug regulatory
authorities, whilst some are used to treat
nervous system and cardiovascular
disorders (Brunton et al., 2011).
A clinical isolate of N. fowleri, sourced
from cerebrospinal fluid of a patient who
died recently of PAM, was grown in 10 ml
Nelson’s medium (Marciano-Cabral &
Cabral, 2007; Visvesvara et al., 2007). The
isolate was maintained in culture for 1
month and its identity confirmed with
PCR using N. fowleri-specific primers
(Yousuf et al., 2013) before testing in this
study. The medium was refreshed 15–20 h
prior to experiments. To determine the
lytic effects of drugs on N. fowleri,
amoebicidal assays were performed.
Briefly, N. fowleri trophozoites were
incubated with different concentrations of
drugs (10–250 mM) in Page’s amoeba
saline (105 trophozoites ml21 per well) in
24-well plates. Plates were incubated at
37 uC for 24 h. Following this incubation,
lytic effects were determined by
haemocytometry, whilst amoebae viability
was determined by inoculating drug-
treated amoebae in fresh growth medium
(Nelson’s medium). In some experiments,
0.1% trypan blue was added, and
numbers of live (non-stained) and dead
(stained) amoebae were counted. N.
fowleri incubated with amoebic saline
alone was used as controls. Data are
representative of at least three
experiments performed in duplicate and
are expressed as mean±SE.
The amoebicidal effects of procyclidine,
digoxin, amlodipine and haloperidol were
determined at micromolar concentrations.
N. fowleri was treated with 200 mM of the
different drugs, targeting vital receptors
and biochemical pathways. The percentage
of amoebae in controls was considered as
100% and the effects of drugs are
expressed as relative change. The findings
revealed that 200 mM digoxin showed
significant lytic effects (P,0.01 using a
paired t-test; one-tail distribution) as
observed by a .90% reduction in
amoebae numbers (Fig. 1). Furthermore,
no viable amoebae were observed post-
treatment when inoculated in the growth
medium for 48 h (data not shown). Even
longer incubations did not allow the re-
emergence of viable amoebae. Similarly,
procyclidine showed potent amoebicidal
effects (Fig. 1). Amlodipine showed a
reduction in amoebae to 19±1.2%
compared with 100% for the controls.
Haloperidol and apomorphine reduced the
amoebae to 21.6±4.8 and 33±0.4%,
respectively, whilst amiodarone and
loperamide showed reductions to 51.8±9
and 73.8±1.6%, respectively.
Overall, of the seven drugs tested, two
(digoxin and procyclidine) showed
effective killing of N. fowleri, whilst
amlodipine showed .80% amoebicidal
effects. Amlodipine is a dihydropyridine
calcium channel blocker used in the
treatment of systemic hypertension and
myocardial ischaemia (Brunton et al.,
2011; Baig et al., 2013). Digoxin is a widely
used positive ionotropic drug that is given
in congestive heart failure and
supraventricular tachycardia that acts
through inhibition of Na/K-ATPase
(Brunton et al., 2011; Baig et al., 2013).
Digoxin crosses both the blood–brain
barrier and the placenta. Following
intravenous administration to healthy
volunteers, 50–70% of the digoxin dose is
excreted unchanged in the urine, and only
a small percentage (~16%) of the given
dose is metabolized with a half-life of
~36 h. The end metabolites include 3-b-
digoxigenin, 3-keto-digoxigenin, and their
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glucuronide and sulfate conjugates (Brunton
et al., 2011). Procyclidine is an anti-
cholinergic agent that is widely used as an
anti-parkinsonian agent because of its anti-
muscarinic action (Brunton et al., 2011; Baig
et al., 2013). Procyclidine primarily
antagonizes muscarinic receptors M1, M2
and M4 (Brunton et al., 2011; Baig et al.,
2013). Another agent, haloperidol, a drug of
the same class as trifluoperazine, produced
potent amoebicidal effects. Haloperidol acts
primarily as a dopamine receptor blocker
and has been used as an anti-psychotic drug.
This is consistent with previous studies
which showed that chlorpromazine is
effective against Acanthamoeba castellanii
(reviewed in Baig et al., 2013). Among the
other drugs tested, apomorphine is a non-
selective dopamine agonist that activates
both D1- and D2-like receptors, with a
preference for the latter subtype (Brunton
et al., 2011; Baig et al., 2013). Amiodarone
resembles thyroxin (a thyroid hormone)
chemically and its binding to the nuclear
thyroid receptor might contribute to its
pharmacological properties.
In conclusion, to the best of our
knowledge, we have shown for the first
time that a diverse group of drugs (some of
which are used currently for central
nervous system disorders) (Brunton et al.,
2011; Baig et al., 2013) affecting cellular
availability of calcium, sodium and
potassium ions through G-protein-
coupled receptors and metabotropic
receptors showed anti-N. fowleri effects.
Future studies will explore the molecular
mechanisms to validate the mode of action
of these drugs in vitro and in vivo. It is
believed that the findings reported here
will be of potential value in the rational
development of therapeutic interventions
Table 1. Clinically available drugs tested in the present study and their known mode(s) of action
Drug Mode(s) of action
Amiodarone Class III antiarrhythmic agent, shows b-blocker-like and potassium-channel-blocker-like actions
Binding to the nuclear thyroid receptor
Amlodipine Calcium antagonist that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle
Acts as a functional inhibitor of acid sphingomyelinase; sphingomyelin is involved in signal transduction and apoptosis (cell
death)
Apomorphine Non-selective (D) dopaminergic receptor agonist
An antagonist at 5-hydroxytryptamine and a-adrenergic receptors
Digoxin Binds to Na/K-transporting ATPase a1 chain to inhibit its function at heart muscle cells and other tissues
Inhibitor of cholesterol side-chain cleavage enzyme, mitochondrial
Haloperidol Dopamine antagonist
Muscarinic receptor antagonist
Histamine antagonist
Loperamide m-Opioid receptor agonist
Calmodulin binder
Procyclidine Blocks the neurotransmitter acetylcholine in the central and the peripheral nervous system at muscarinic receptors
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Fig. 1. Lytic effects of various drugs determined by haemocytometry. Briefly, N. fowleri (105 amoebae) were incubated with and
without various drugs (200 mM) at 37 6C for 24 h in Page’s amoeba saline, followed by counting of amoebae. The percentage
of amoebae in controls was considered as 100% and the effects of drugs are expressed as relative change. At 200 mM, digoxin
and procyclidine showed potent lytic effects. The results are representative of three independent experiments performed in
duplicate. Data are presented as mean±SE.
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and open up new fields of research against
the devastating effects of PAM.
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